Browse by Journal Title

Article

Cox proportional hazards deep neural network identifies peripheral blood complete remission to be at least equivalent to morphologic complete remission in predicting outcomes of patients treated with azacitidine - a prospective cohort study by the AGMT.
Pleyer, L. and Vaisband, M. and Drost, M. and Pfeilstöcker, M. and Stauder, R. and Heibl, S. and Sill, H. and Girschikofsky, M. and Stampfl-Mattersberger, M. and Pichler, A. and Hartmann, B. and Petzer, A. and Schreder, M. and Schmitt, C.A. and Vallet, S. and Melchardt, T. and Zebisch, A. and Pichler, P. and Zaborsky, N. and Machherndl-Spandl, S. and Wolf, D. and Keil, F. and Hasenauer, J. and Larcher-Senn, J. and Greil, R.
American Journal of Hematology 98 (11): 1685-1698. November 2023

ABVD vs BEACOPP escalated in advanced-stage Hodgkin's lymphoma: Results from a multicenter European study.
Mondello, P. and Musolino, C. and Dogliotti, I. and Bohn, J.P. and Cavallo, F. and Ferrero, S. and Botto, B. and Cerchione, C. and Nappi, D. and De Lorenzo, S. and Martinelli, G. and Wolf, D. and Schmitt, C. and Loseto, G. and Cuzzocrea, S. and Willenbacher, W. and Mian, M. and Straus, D.J.
American Journal of Hematology 95 (9): 1030-1037. September 2020

Genome-wide association study follow-up identifies cyclin A2 as a regulator of the transition through cytokinesis during terminal erythropoiesis.
Ludwig, L.S. and Cho, H. and Wakabayashi, A. and Eng, J.C. and Ulirsch, J.C. and Fleming, M.D. and Lodish, H.F. and Sankaran, V.G.
American Journal of Hematology 90 (5): 386-91. May 2015

Imatinib in Philadelphia chromosome-positive chronic phase CML patients: molecular and cytogenetic response rates and prediction of clinical outcome.
Le Coutre, P. and Kreuzer, K.A. and Na, I.K. and Schwarz, M. and Lupberger, J. and Holdhoff, M. and Baskaynak, G. and Gschaidmeier, H. and Platzbecker, U. and Ehninger, G. and Prejzner, W. and Huhn, D. and Schmidt, C.A.
American Journal of Hematology 73 (4): 249-255. August 2003

Cytogenetic and molecular characterization of a patient with simultaneous B-cell chronic lymphocytic leukemia and peripheral T-cell lymphoma.
Martin-Subero, J.I. and Siebert, R. and Harder, L. and Gesk, S. and Schwindt, P. and Braeuninger, A. and Willenbrock, K. and Steinemann, D. and Tiemann, M. and Calasanz, M.J. and Grote, W. and Ludwig, W.D. and Hansmann, M.L. and Schlegelberger, B.
American Journal of Hematology 68 : 276-279. 1 December 2001

Giant platelet disorder in a patient with type 2B von Willebrand's disease.
Moll, S. and Lazarowski, A.R. and White, G.C.
American Journal of Hematology 57 : 62-67. 1 January 1998

Human Lyb-2 homolog CD72 is a marker for progenitor B-cell leukemias.
Schwarting, R. and Castello, R. and Moldenhauer, G. and Pezzutto, A. and von Hoegen, I. and Ludwig, W.D. and Parnes, J.R. and Doerken, B.
American Journal of Hematology 41 : 151-158. 1 January 1992